Touchstone
Last syncNov 1, 2026, 6:55 PM ET

SI

Shoulder Innovations, Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$19.13Close $394.5MMarket cap $11.01 – $24.2552-week range Nov 5, 2026Next report · after the close

Highlights

Cautions

  • Trend not confirmed 7 of 8 conditions · under the 50-day
  • Results soon Nov 5, 2026, in 4 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 21%
1wk down 2.7% price change
1mo up 1.2% price change
12-month return up 61% market up 11% · its own up 52%
F-score — — Not assessed
Altman Z 8.09 Low risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 2.8× price / book
Earnings yield down 6.9% EBIT / enterprise value
Cheaper than — of the market · not assessed
Revenue growth up 50% year on year
EPS growth — latest quarter
Sales growth up 56% latest quarter · -9 pts
ROE down 29% return on equity
Free cash margin down 76% -$36.0M FCF
D/E 0.11 long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest

Trade setup

ATR% 5.5% $1.06 a day · 2×ATR $17.01
RS 79 / 99 vs the universe
Trend 7 / 8 under the 50-day
Relative volume 1.1× vs 50-day average
Up/down volume 0.96 50 sessions
Implied move — no option chain · report Nov 5, 2026
Trend template · 7 of 8
  • Price above the 50-day average: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Shareholders diluted The share count rose 24486.3% over the year, from 0m to 21m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported Aug 6, 2026
Results reaction Aug 6, 2026-9% vs market2 sessions after results

Financials

2 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $47.3M +50% on FY2024
$0 $50M FY24 FY25 FY2024 · $31.6M FY2025 · $47.3M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$40.4M
-$50M $0 FY24 FY25 FY2024 · -$15.6M FY2025 · -$40.4M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology -$36.0M
-$50M $0 FY24 FY25 FY2024 · -$18.2M FY2025 · -$36.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 77%
  • Net -85%
  • Free cash -76%
-100% 0% 100% FY24 FY25 FY2024 · Gross 77% · Net -49% · Free cash -57% FY2025 · Gross 77% · Net -85% · Free cash -76%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $12.0M net cash
  • Cash
  • Long-term debt
$0 $50M FY24 FY25 FY2024 · Cash $6.1M · Long-term debt $14.7M FY2025 · Cash $26.9M · Long-term debt $14.9M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 20.62m +24486.3% since FY2024
20.62m 83.88k FY24 FY25 FY2024 · 83.88k FY2025 · 20.62m
  FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $31.6M $47.3M
Gross margin 77% 77%
Operating income -$14.7M -$26.3M
Net income -$15.6M -$40.4M
Net margin -49% -85%
Earnings per share -$242.04 -$4.65
Free cash flow -$18.2M -$36.0M
Free cash margin -57% -76%
Cash $6.1M $26.9M
Long-term debt $14.7M $14.9M
Shareholders' equity -$54.7M $140.8M
Shares outstanding 83.88k 20.62m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 13, 2026 Quarterly ↗ Mar 31, 2026 43d
Mar 10, 2026 Annual ↗ Dec 31, 2025 69d
Nov 12, 2025 Quarterly ↗ Sep 30, 2025 43d
Sep 9, 2025 Quarterly ↗ Jun 30, 2025 71d

Current reports

FiledDisclosed
Oct 8, 2026 Regulation FD ↗
Aug 10, 2026 Regulation FD ↗
Aug 6, 2026 Results ↗
Jun 29, 2026 Material agreement · Agreement ended · New obligation · Regulation FD ↗
Jun 26, 2026 Shareholder vote ↗
May 13, 2026 Results ↗
Apr 27, 2026 Regulation FD ↗
Apr 14, 2026 Material agreement ↗
Mar 10, 2026 Results · Director or officer change ↗
Mar 2, 2026 Director or officer change · Regulation FD ↗
Dec 3, 2025 Regulation FD ↗
Nov 12, 2025 Results ↗